Environmental Health Center

Precision Regenerative Medicine

Chronic disease is most prevalent in the elderly and ultimately stems from a multifactorial combination of aging, genetic predisposition, and lifelong epigenetic priming that together can limit the regenerative capacity of our organs. Our Research Unit, Precision Regenerative Medicine (PRM) works on the mechanistic dissection of human lung biology and aims at pioneering regenerative reprogramming therapy in chronic lung disease patients that will increase the healthspan and resilience of aged and diseased lungs.  

Follow us on X

Discovair_3D image of Lungs

Our Research in a Nutshell

Modern single-cell analysis technologies rapidly generate a growing number of cell type and cell state atlases in the healthy and diseased lung. Emerging spatial methods further position the associated gene programs in the context of tissue architecture and enable the systematic deciphering of local cell communication programs. Under disease conditions, ectopic or aberrant cell types or -states regularly emerge, but their significance is often unknown. An outstanding challenge for medical research is 1) to define early deviation points of the lifelong cellular state trajectories from normal to early disease, 2) to explain causative cellular and molecular aberrations driving the disease, 3) to identify suitable intervention junctions to reprogram altered tissue states back to homeostasis and 4) to analyze cellular modes of responsiveness to therapeutic intervention.  

Lung disease is the second most common cause of death globally. Even though the lungs' regenerative capacity, which is mediated through different stem cell populations, is very high, the ability for organ regeneration is often lost in the aging process and various chronic lung diseases. We aim to advance experimental systems medicine by analyzing lifelong trajectories spanning pediatric lung health all the way to lung aging to identify individuals at respiratory risk and early stages of disease.  

Together with our network of clinical collaborators we leverage single cell multi-omics technologies for observations of cellular and molecular events in different patient cohorts and aim at linking these observations to electronic health records and patient (epi-)genetics. We also work on reverse translation of these ground truths observed in patient samples to human organotypic models as well as mouse models of disease. Using functional single cell genomics and proteomics coupled with generative AI, we interrogate cellular circuit mechanisms in the pre-clinical model systems and going forward aim to translate these insights into preventative and regenerative therapy regimes.  

People at PRM

See all
Herbert Schiller Director PRM
Prof. Dr. Herbert Schiller

Director, PRM

View profile
Martin portrait
Dr. Martin Mück-Häusl

Deputy Director, PRM

View profile
Rizqah Kamies portrait
Dr. Rizqah Kamies

Postdoctoral Fellow

Lena Cords PostDoc PRM
Dr. Lena Cords

Postdoctoral Fellow, PRM

Safouane Kadri
Dr. Safouane Kadri

Postdoctoral Fellow

Jelmer Vlasma selfie
Dr. Jelmer Vlasma

Postdoctoral Fellow

News

See all
Graphical abstract for Publication press release

PRM,

A Single Molecular Switch Decides When Lung Cells Turn Fibrotic

The Precision Regenerative Medicine group at Helmholtz Munich has identified a key molecular switch that tells a lung cell to become a scar-forming myofibroblast. It responds to the stiffness of the surrounding tissue, and is necessary as well as…

Read more

Hand holding trophy cup tophy form lines, triangles and particle style design. Illustration vector

PRM,

Ms. Anja Michl and Dr. Rizqah Kamies Share Poster Prize at DZL Annual Meeting 2026

Congratulations to Ms. Anja Michl and Dr. Rizqah Kamies, who were jointly awarded a poster prize for their shared work at the DZL Annual Meeting 2026, held in Wiesbaden, Germany in June 2026.


The DZL (German Center for Lung Research) Annual Meeting…

Read more

Young business team receiving award prize at best business project competition event. Business and entrepreneurship award ceremony theme. Focus on unrecognizable people in audience.

PRM,

Dr. Lena Cords Receives Poster Prize at ERS Lung Science Conference 2026

We are delighted to announce that Dr. Lena Cords has been awarded the Poster Award by the European Respiratory Society (ERS) at the Lung Science Conference 2026, which took place in Estoril, Portugal.

At the conference, Dr. Cords presented her…

Read more

doctor supervisor looking at the microscope slide in the forensic,Laboratory Medical scientists working at lab with test tubes researcher performs liquid

PRM,

Former PRM Member Dr. Yang Establishes His Independent Research Group in China

We are delighted to announce that Dr. Lin Yang, a long-standing member of PRM and LHI, has officially started his own research group in China as of January 2026. Over the course of his postdoctoral work in Herbert Schiller’s group at Helmholtz…

Read more

Lung Cell Atlas

AI, Environmental Health, PRM, Computational Health,

Helmholtz Munich and Parse Biosciences Collaborate on Human Lung Tissue Perturbation Atlas

Helmholtz Munich and Parse Biosciences have entered into a collaboration to generate one of the most comprehensive lung disease perturbation atlases to date. The project uses a human lung ex vivo tissue slice culture model derived from both healthy…

Read more

Human lung model

AI, Environmental Health, PRM, Computational Health, ICB,

New Collaboration to Advance Drug Discovery for Pulmonary Fibrosis

Helmholtz Munich and Boehringer Ingelheim have started a research collaboration to identify new avenues for the treatment of idiopathic pulmonary fibrosis that could improve outcomes in people living with this severe and progressive lung disease.…

Read more

Highlight

Publications

Our Research Unit in Numbers

19
Employees
78
Publications
5
Post Docs
8
PhDs
8
Nationalities

Contact

Herbert Schiller Director PRM
Prof. Dr. Herbert Schiller

Director, PRM

View profile

Martin portrait
Dr. Martin Mück-Häusl

Deputy Director, PRM

View profile

Funders and Consortia

  1. German Center for Lung Research (DZL) - Deutsches Zentrum für Lungenforschung (dzl.de)
  2. Single Cell Omics Germany - Single Cell Omics Germany
  3. Human Cell Atlas consortium - Home (humancellatlas.org)
  4. RESPIRE-EXCEL consortium funded by EU - Respire-excel
  5. TRR 359 PILOT funded by the German Research Foundation (DFG) - TRR 359 PILOT | perinatal immunity immunology TRR 359 PILOT (perinatal-immunity.de)
  6. GRK 2338 funded by the German Research Foundation (DFG) - RTG 2338 Targets in Toxicology - LMU Munich (uni-muenchen.de)
  7. Human Lung Cell Atlas 1.0 consortium funded by the Chan Zuckerberg Initiative - Human Lung Cell Atlas 1.0 - Chan Zuckerberg Initiative
  8. MPII consortium funded by the Chan Zuckerberg Initiative - Mapping the Pediatric Inhalation Interface: Nose, Mouth, and Airways, - Chan Zuckerberg Initiative
  9. COVIPA consortium funded by the Helmholtz Association and the Federal Ministry of Education and Research - Virological and immunological determinants of COVID-19 pathogenesis - lessons to get prepared for future pandemics (dkfz.de)
  10. Postdoctoral Fellowships funded by the European Respiratory Society - ERS (ersnet.org), EMBO – Excellence in life sciences and Home - Marie Skłodowska-Curie Actions (europa.eu).

Research Collaborators

  1. Prof. Fabian J Theis – Helmholtz Munich, Germany
  2. Prof. Matthias Mann – Max Planck Institute of Biochemistry, Germany
  3. Prof. Richard Scheltema – University of Liverpool, UK
  4. Prof. Purushothama Rao Tata – Duke University, USA
  5. Prof. Wim Wuyts & Dr. Laurens De Sadeleer – KU Leuven, Belgium
  6. Prof. Scott Budinger & Prof. Alexander Misharin – Northwestern University Chicago, USA
  7. Prof. Melanie Königshoff – University of Pittsburgh, USA
  8. Prof. Christos Samakovlis – SciLife Lab, Sweden
  9. Prof. Martijn Nawijn – University of Groningen, Netherlands

Looking for a new challenge?

Join our team.